|Videos|December 27, 2017

Universal Flu Vaccine: Is It Possible?

William Schaffner, MD, discusses efforts to develop a universal flu vaccine.

William Schaffner, MD, medical director of the National Foundation for Infectious Diseases, discusses efforts to develop a universal flu vaccine.

Interview Transcript (modified slightly for readability):

“Scientists in universities, in the federal government, in the vaccine industry are all working to create better influenza vaccines. For example, we now have two vaccines formulated for people aged 65 and older; they work better. And, some of my friends are working in the laboratory to create a universal flu vaccine, one that would cover a whole variety of strains, which, perhaps, we might only have to get every five or ten years.

But that’s not the vaccine we have today. The vaccine we have today has to be given each and every year. So, let’s use the one that we have today to our best advantage, while we have a look to the future and high hopes down the road.”


Related to this article

NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.